We are live on
!
Find out more
AC
Armistice Capital Portfolio holdings
AUM
$5.62B
1-Year Est. Return
36.06%
This Fund
S&P 500
This Quarter
Est. Return
+0.86%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$5.8B
AUM Growth
-$877M
(-13%)
Cap. Flow
-$1.07B
Cap. Flow
% of AUM
-18.41%
Top 10 Holdings %
Top 10 Hldgs %
67.63%
Holding
285
New
60
Increased
42
Reduced
77
Closed
80
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McDonald's
MCD
|
+$31.9M |
| 2 |
GE HealthCare
GEHC
|
+$31.5M |
| 3 |
ImmunityBio
IBRX
|
+$20.9M |
| 4 |
GitLab
GTLB
|
+$14.8M |
| 5 |
Verastem
VSTM
|
+$13.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EXAS
Exact Sciences
EXAS
|
+$52.3M |
| 2 |
Spectrum Brands
SPB
|
+$49.4M |
| 3 |
Simply Good Foods
SMPL
|
+$46.6M |
| 4 |
Boston Beer
SAM
|
+$42M |
| 5 |
Domino's
DPZ
|
+$41.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.42% |
| 2 | Consumer Discretionary | 5.85% |
| 3 | Technology | 4.99% |
| 4 | Consumer Staples | 1.48% |
| 5 | Communication Services | 1.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Oxbridge Re Holdings
OXBR
$12.6M
| – | – |
-622,165
| Closed | -$1.18M |
|
252
Palisade Bio
PALI
$368M
| – | – |
-144,764
| Closed | -$98.6K |
|
253
Processa Pharmaceuticals
PCSA
$6.06M
| – | – |
-2,240
| Closed | -$20.7K |
|
254
Pfizer
PFE
$147B
| – | – |
-211,740
| Closed | -$5.37M |
|
|
PTN
255
Palatin Technologies
PTN
$14.1M
| – | – |
-33,432
| Closed | -$974K |
|
256
RxSight
RXST
$260M
| – | – |
-142,036
| Closed | -$3.59M |
|
257
Scilex Holding
SCLX
$45.9M
| – | – |
-394,057
| Closed | -$3.43M |
|
258
Shake Shack
SHAK
$3B
| – | – |
-285,021
| Closed | -$25.1M |
|
259
Shuttle Pharmaceuticals
SHPH
$2.69M
| – | – |
-282
| Closed | -$27.4K |
|
|
SKX
260
DELISTED
Skechers
SKX
| – | – |
-295,340
| Closed | -$16.8M |
|
|
261
Simply Good Foods
SMPL
$989M
| – | – |
-1,351,593
| Closed | -$46.6M |
|
262
SharkNinja
SN
$25.8B
| – | – |
-210,359
| Closed | -$17.5M |
|
263
Sanofi
SNY
$103B
| – | – |
-524,000
| Closed | -$29.1M |
|
|
264
Spectrum Brands
SPB
$2.08B
| – | – |
-691,000
| Closed | -$49.4M |
|
265
SuperCom
SPCB
$67.3M
| – | – |
-363,470
| Closed | -$2.42M |
|
266
S&P Global
SPGI
$121B
| – | – |
-1,005
| Closed | -$511K |
|
|
STKH
267
Steakholder Foods
STKH
$1.52M
| – | – |
-1,325
| Closed | -$164K |
|
268
Target
TGT
$67.1B
| – | – |
-19,733
| Closed | -$2.06M |
|
269
TransUnion
TRU
$15.3B
| – | – |
-12,000
| Closed | -$996K |
|
270
Trevi Therapeutics
TRVI
$2.65B
| – | – |
-2,988,000
| Closed | -$18.8M |
|
271
Texas Roadhouse
TXRH
$13.7B
| – | – |
-164,701
| Closed | -$27.4M |
|
|
VRNA
272
DELISTED
Verona Pharma
VRNA
| – | – |
-68,201
| Closed | -$4.33M |
|
273
Vertex Pharmaceuticals
VRTX
$123B
| – | – |
-50,000
| Closed | -$24.2M |
|
274
Catheter Precision
VTAK
$996K
| – | – |
-13,209
| Closed | -$86.3K |
|
275
Wyndham Hotels & Resorts
WH
$5.65B
| – | – |
-199,983
| Closed | -$18.1M |
|
Similar funds
CRC
RMDI
F
EW
O
DSC
ACM
PI
Armistice Capital's Q2 2025 Portfolio in Review
As of Q2 2025, Armistice Capital held 285 positions worth $5.8B, down 13% from $6.67B the previous quarter. Its ten largest holdings account for 68% of the portfolio.
Armistice Capital withdrew a net $1.07B in Q2 2025, closing 80 positions and reducing 77 holdings. Its most notable exit was Spectrum Brands, an estimated $49.4M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 35% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Armistice Capital opened a new position in ImmunityBio worth $20.5M.
- Armistice Capital's largest Q2 2025 buy was ImmunityBio: 7,764,000 shares worth $20.5M.
- Armistice Capital added most to McDonald's in Q2 2025, an estimated $31.9M increase.
- Armistice Capital's biggest Q2 2025 reduction was Exact Sciences, cutting an estimated $52.3M.
- Armistice Capital fully exited Spectrum Brands in Q2 2025, selling an estimated $49.4M.
- Armistice Capital's ten largest holdings make up 68% of its $5.8B portfolio in Q2 2025.
- Armistice Capital opened 60 new positions and closed 80 in Q2 2025.
- Armistice Capital's portfolio value fell 13% quarter-over-quarter to $5.8B.
Based on Armistice Capital's 13F filing for Q2 2025, filed 14 Aug 2025.